Skip to main content

August 2025

Pharma Courses

Applications are invited for Project Associate at NIIST

M.Sc in Chemistry / Applied Chemistry / Organic Chemistry / Polymer Chemistry / Materials Science or equivalent from recognized University or Equivalent and 3 years of experience in R&D in Industrial and Academic Institutions.
Openings in Production Department at Macleods - B.Pharm, BSc Apply
Years of experience in Granulation/ Compression/ Coating/ Capsule Filling/ Liquid Manufacturing/ Packaging
Openings for B.Pharm, MSc in Production, QC, Store at Aarti Pharmalabs Limited
Hands-on experience in batch operations, GMP documentation, shift handling, and operation of equipment like reactors, centrifuges, and dryers.
Anixa Biosciences secures New U.S. Patent extending CAR-T Cancer Therapy Protection to 2045
Anixa Biosciences, Inc., a clinical-stage biotechnology company specializing in cancer treatment and prevention, has announced the issuance of a new U.S. patent for its chimeric antigen receptor-T cell (CAR-T) technology.
Zydus Lifesciences delivers steady growth in Q1 FY26, boosted by global expansion

Zydus Lifesciences Limited reported a steady performance for the quarter ended June 30, 2025, with growth across key geographies and strong contributions from innovation-driven initiatives. The pharmaceutical major posted revenue from operations of Rs. 65,737 million, marking a 6% increase year-on-year and a marginal 0.7% rise from the previous quarter. Net profit stood at Rs. 14,668 million, up 3% from the same quarter last year and a robust 25.3% higher than Q4 FY25.

Indoco Remedies receives final ANDA approval from USFDA for Rivaroxaban Tablets
Indoco Remedies Ltd. announced final approval of the Company Abbreviated New Drug Application (ANDA) for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg, to market a generic equivalent to the reference listed drug (RLD), Xarelto Tablets, 2.5 mg, 10 mg, 15 mg and 20 mg, of Janssen Pharmaceuticals, Inc. (Janssen), from USFDA.
Padcev™ plus keytruda™ significantly improves survival for certain patients with bladder cancer when given before and after surgery
Pfizer Inc. and Astellas Pharma Inc. announced positive topline results from the Phase 3 EV-303 clinical trial (also known as KEYNOTE-905).
Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology
Bayer and Kumquat Biosciences Inc., a clinical-stage biotech company founded by pioneers of the KRAS pathway, today announced that they have entered into an exclusive global license and collaboration to develop and commercialize Kumquats KRAS G12D inhibitor.
Research Interns (16 posts) require at CSIR R&D organization - B.Pharm, MSc may apply
Bachelors degree in Pharmacy or M.Sc with 1st Class or equivalent GPA in the area of Chemistry / Life Science. CSIR the premier industrial R&D organization in India
Openings for Pharmacists (6 posts) at the office of Chief Medical Officer
D.Pharm / B.Pharm ; The applicant must compulsorily present the original copy of the documents and certificates attached with him for document verification.